HK Stock MarketDetailed Quotes
06955 BOAN BIOTECH
- 8.950
- -0.130-1.43%
Market Closed Aug 9 16:08 CST
4.80BMarket Cap-36382P/E (TTM)
9.150High8.940Low160.40KVolume9.010Open9.080Pre Close1.45MTurnover0.03%Turnover RatioLossP/E (Static)535.93MShares24.20052wk High3.29P/B4.80BFloat Cap8.80052wk Low--Dividend TTM535.93MShs Float40.000Historical High--Dividend LFY2.31%Amplitude8.800Historical Low9.041Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
BOAN BIOTECH Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|
| Turnover | 19.80%618.13M | 18.37%261.23M | 225.11%515.96M | 1,724.79%220.69M | --158.7M | --12.09M | ---- |
| Operating income | 19.80%618.13M | 18.37%261.23M | 225.11%515.96M | 1,724.79%220.69M | 158.7M | 12.09M | |
| Cost of sales | -29.33%-209.16M | -40.31%-103.02M | -209.89%-161.73M | -2,117.49%-73.42M | ---52.19M | ---3.31M | ---- |
| Operating expenses | -29.33%-209.16M | -40.31%-103.02M | -209.89%-161.73M | -2,117.49%-73.42M | -52.19M | -3.31M | |
| Gross profit | 15.45%408.97M | 7.43%158.22M | 232.57%354.23M | 1,576.75%147.27M | 106.51M | 8.78M | |
| Selling expenses | -19.83%-256.53M | -16.16%-117.12M | -296.10%-214.09M | -1,616.50%-100.83M | ---54.05M | ---5.87M | ---- |
| Administrative expenses | 37.22%-51.69M | 29.31%-26.55M | -95.27%-82.33M | -106.16%-37.56M | -844.56%-42.17M | ---18.22M | ---4.46M |
| Research and development expenses | 42.38%-230.68M | 25.45%-126.03M | -72.88%-400.34M | -51.54%-169.06M | 2.01%-231.57M | ---111.56M | ---236.32M |
| Special items of operating profit | 1.89%24.64M | -111.37%-1.54M | 224.73%24.19M | 198.98%13.51M | -38.25%7.45M | --4.52M | --12.06M |
| Operating profit | 66.93%-105.29M | 22.94%-113.02M | -48.88%-318.34M | -19.88%-146.67M | 6.51%-213.82M | -122.35M | -228.72M |
| Financing cost | -5.07%-14.09M | 5.54%-6.26M | -15.59%-13.41M | -18.78%-6.62M | 1.86%-11.6M | ---5.58M | ---11.82M |
| Earning before tax | 64.02%-119.38M | 22.19%-119.27M | -47.17%-331.75M | -19.83%-153.3M | 6.29%-225.42M | -127.93M | -240.54M |
| Tax | ---- | ---239K | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 64.02%-119.38M | 22.04%-119.51M | -47.17%-331.75M | -19.83%-153.3M | 6.29%-225.42M | -127.93M | -240.54M |
| Earning after tax | 64.02%-119.38M | 22.04%-119.51M | -47.17%-331.75M | -19.83%-153.3M | 6.29%-225.42M | -127.93M | -240.54M |
| Profit attributable to shareholders | 64.02%-119.38M | 22.04%-119.51M | -47.17%-331.75M | -19.83%-153.3M | 6.29%-225.42M | -127.93M | -240.54M |
| Basic earnings per share | 65.67%-0.23 | 25.81%-0.23 | -42.55%-0.67 | -10.71%-0.31 | 92.33%-0.47 | -0.28 | -6.13 |
| Diluted earnings per share | 65.67%-0.23 | 25.81%-0.23 | -42.55%-0.67 | -10.71%-0.31 | 92.33%-0.47 | -0.28 | -6.13 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg